HUP9903706A3 - 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same - Google Patents
4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the sameInfo
- Publication number
- HUP9903706A3 HUP9903706A3 HU9903706A HUP9903706A HUP9903706A3 HU P9903706 A3 HUP9903706 A3 HU P9903706A3 HU 9903706 A HU9903706 A HU 9903706A HU P9903706 A HUP9903706 A HU P9903706A HU P9903706 A3 HUP9903706 A3 HU P9903706A3
- Authority
- HU
- Hungary
- Prior art keywords
- dihydronaphth
- isoxazoles
- derivatives
- preparation
- pharmaceutical compositions
- Prior art date
Links
- IHHJKWJJZUXWFI-UHFFFAOYSA-N 4,5-dihydrobenzo[g][2,1]benzoxazole Chemical class C1=CC=C2C3=NOC=C3CCC2=C1 IHHJKWJJZUXWFI-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58331996A | 1996-01-05 | 1996-01-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9903706A2 HUP9903706A2 (hu) | 2000-08-28 |
HUP9903706A3 true HUP9903706A3 (en) | 2000-09-28 |
Family
ID=24332609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903706A HUP9903706A3 (en) | 1996-01-05 | 1996-12-12 | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0874833A1 (xx) |
JP (1) | JP3161737B2 (xx) |
KR (1) | KR100308748B1 (xx) |
CN (1) | CN1214046A (xx) |
AR (1) | AR005347A1 (xx) |
AU (1) | AU710059B2 (xx) |
BR (1) | BR9612578A (xx) |
CA (1) | CA2241845C (xx) |
HU (1) | HUP9903706A3 (xx) |
IL (1) | IL125197A0 (xx) |
NO (1) | NO983100L (xx) |
NZ (1) | NZ325587A (xx) |
WO (1) | WO1997025317A1 (xx) |
ZA (1) | ZA9725B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050131051A1 (en) * | 2000-08-21 | 2005-06-16 | Shaomeng Wang | 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
CA2480113C (en) * | 2002-04-02 | 2012-04-24 | Janssen Pharmaceutica N.V. | Substituted amino isoxazoline derivatives and their use as anti-depressants |
TW200409777A (en) * | 2002-08-12 | 2004-06-16 | Janssen Pharmaceutica Nv | C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
EP1554286B1 (en) | 2002-08-15 | 2010-01-27 | Janssen Pharmaceutica N.V. | Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
US7462717B2 (en) * | 2002-08-21 | 2008-12-09 | Janssen Pharmaceutica N.V. | C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants |
US8025859B2 (en) | 2007-05-18 | 2011-09-27 | Cesl Limited | Process for gold and silver recovery from a sulphide concentrate |
EP2592071B1 (en) | 2009-10-29 | 2019-09-18 | Bristol-Myers Squibb Company | Tricyclic heterocyclic compounds |
CN110234633A (zh) | 2016-09-02 | 2019-09-13 | 百时美施贵宝公司 | 取代的三环杂环化合物 |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
WO2019032632A1 (en) | 2017-08-09 | 2019-02-14 | Bristol-Myers Squibb Company | ALKYLPHENYL COMPOUNDS |
KR102002633B1 (ko) | 2018-07-19 | 2019-07-22 | 김태효 | 완충이격부가 구비된 논슬립 발의류 |
KR102429797B1 (ko) | 2019-12-31 | 2022-08-05 | 주식회사 제이패션 | 기능성 무재봉 덧신 및 이를 제조하는 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2119977A1 (en) * | 1971-04-23 | 1971-12-16 | Teikoku Hormone Manufacturing Co , Ltd, Tokio | Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation |
DK0402644T3 (da) * | 1989-05-19 | 1996-01-02 | Hoechst Roussel Pharma | N-(Aryloxyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner, fremgangsmåde til deres fremstilli ng samt deres anvendelse som medikamenter |
EP0665840A1 (en) * | 1992-10-23 | 1995-08-09 | MERCK SHARP & DOHME LTD. | Dopamine receptor subtype ligands |
-
1996
- 1996-12-12 AU AU14126/97A patent/AU710059B2/en not_active Ceased
- 1996-12-12 JP JP52519797A patent/JP3161737B2/ja not_active Expired - Fee Related
- 1996-12-12 HU HU9903706A patent/HUP9903706A3/hu unknown
- 1996-12-12 EP EP96944274A patent/EP0874833A1/en not_active Withdrawn
- 1996-12-12 NZ NZ325587A patent/NZ325587A/xx unknown
- 1996-12-12 CA CA002241845A patent/CA2241845C/en not_active Expired - Fee Related
- 1996-12-12 KR KR1019980705166A patent/KR100308748B1/ko not_active IP Right Cessation
- 1996-12-12 IL IL12519796A patent/IL125197A0/xx unknown
- 1996-12-12 BR BR9612578A patent/BR9612578A/pt not_active Application Discontinuation
- 1996-12-12 WO PCT/US1996/019569 patent/WO1997025317A1/en not_active Application Discontinuation
- 1996-12-12 CN CN96180175A patent/CN1214046A/zh active Pending
-
1997
- 1997-01-02 ZA ZA9725A patent/ZA9725B/xx unknown
- 1997-01-03 AR ARP970100015A patent/AR005347A1/es unknown
-
1998
- 1998-07-03 NO NO983100A patent/NO983100L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ325587A (en) | 1999-02-25 |
EP0874833A1 (en) | 1998-11-04 |
WO1997025317A1 (en) | 1997-07-17 |
HUP9903706A2 (hu) | 2000-08-28 |
AU1412697A (en) | 1997-08-01 |
CA2241845A1 (en) | 1997-07-17 |
NO983100D0 (no) | 1998-07-03 |
ZA9725B (en) | 1997-07-07 |
KR100308748B1 (ko) | 2001-12-12 |
NO983100L (no) | 1998-09-04 |
IL125197A0 (en) | 1999-03-12 |
AU710059B2 (en) | 1999-09-09 |
BR9612578A (pt) | 1999-07-27 |
AR005347A1 (es) | 1999-04-28 |
CA2241845C (en) | 2002-10-01 |
CN1214046A (zh) | 1999-04-14 |
JP3161737B2 (ja) | 2001-04-25 |
JPH11510816A (ja) | 1999-09-21 |
KR19990077033A (ko) | 1999-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0001607A3 (en) | Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds | |
HUP9602122A3 (en) | Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
IL115483A0 (en) | Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP9603495A3 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
HUP9700709A3 (en) | 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds | |
HUP0001652A3 (en) | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
HUP9800138A3 (en) | 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
IL112193A0 (en) | Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
IL98873A0 (en) | Benzodiazepine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL113103A0 (en) | Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
HUP9903706A3 (en) | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same | |
HUP9904514A3 (en) | 5h-pyrrolo[2,1-c][1,4]-benzodiazepin 3-carboxamide derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0002650A3 (en) | 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0003624A3 (en) | 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives, pharmaceutical compositions containing them and process for their preparation | |
HUP9602868A3 (en) | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation | |
IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
CZ346595A3 (en) | Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof | |
HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them | |
IL127133A (en) | 7 -(3' - o - acyl- 5' - c - substituted - 4 '- o - alkyl - ?? - l - lyxopyranosyloxy) - 4 - hydroxy - 3 -substituted - 2h -1 - benzopyran - 2 - one derivatives, preparation process and pharmaceutical compositions containing them |